Caitlin E. Martin

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 24 papers. Top paper: “Sex‐specific risk profiles for substance use among college students”.

Sex‐specific risk profiles for substance use among college students

Brain and Behavior(2020)10.1002/brb3.1959

N/A

0DataRank · unranked

14 citations

Albert J. Ksinan, F. Gerard Moeller, Danielle M. Dick, Spit for Science Working Group, Caitlin E. Martin

Buprenorphine Dosing for the Treatment of Opioid Use Disorder Through Pregnancy and Postpartum

Current Treatment Options in Psychiatry(2020)10.1007/s40501-020-00221-z

N/A

0DataRank · unranked

32 citations

Caroline Shadowen, Bhushan Thakkar, Travis Oakes, Tamas S. Gal, F. Gerard Moeller +1 more

Caring for women with substance use disorders through pregnancy and postpartum during the COVID-19 pandemic: Lessons learned from psychology trainees in an integrated OBGYN/substance use disorder outpatient treatment program

Journal of Substance Abuse Treatment(2020)10.1016/j.jsat.2020.108200

N/A

0DataRank · unranked

25 citations

Anna Beth Parlier‐Ahmad, Julia Brechbiel, Leila Z. Islam, Caitlin E. Martin, Jaclyn S. Sadicario

Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease

Carolina Digital Repository (University of North Carolina at Chapel Hill)(2020)10.17615/jf9m-1g45

N/A

0DataRank · unranked

9 citations

Millie D. Long, Michael D. Kappelman, Caitlin E. Martin, Robert S. Sandler

Recovery capital among people receiving treatment for opioid use disorder with buprenorphine

Harm Reduction Journal(2021)10.1186/s12954-021-00553-w

N/A

0DataRank · unranked

21 citations

Mishka Terplan, Dace S. Svikis, Laura Peyton Ellis, Caitlin E. Martin, Anna Beth Parlier‐Ahmad

Pre-exposure prophylaxis (PrEP) indication and uptake among people receiving buprenorphine for the treatment of opioid use disorder

Journal of Substance Abuse Treatment(2021)10.1016/j.jsat.2021.108506

N/A

0DataRank · unranked

17 citations

Anna Beth Parlier‐Ahmad, Caitlin E. Martin, Lori Beck

Initiation and Treatment Discontinuation of Medications for Opioid Use Disorder in Pregnant People Compared With Nonpregnant People

Obstetrics and Gynecology(2023)10.1097/aog.0000000000005117

N/A

0DataRank · unranked

28 citations

Hendrée E. Jones, Davida M. Schiff, Caitlin E. Martin, Jeannie C. Kelly, Ebony B. Carter +3 more

Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: An analysis of insurance claims

Drug and Alcohol Dependence Reports(2023)10.1016/j.dadr.2023.100195

N/A

0DataRank · unranked

17 citations

Vivien Huang, Arthur Robin Williams, Caitlin E. Martin, Alexander R. Bazazi, Richard A. Grucza +1 more

Benzodiazepine, Z-drug, and sleep medication prescriptions in male and female people with opioid use disorder on buprenorphine and comorbid insomnia: an analysis of multistate insurance claims

SLEEP(2023)10.1093/sleep/zsad083

N/A

0DataRank · unranked

8 citations

Hetal Patel, Joseph M. Dzierzewski, F. Gerard Moeller, Laura J. Bierut, Richard A. Grucza +2 more

Postpartum medication for opioid use disorder outcomes associated with prenatal treatment and neighborhood-level social determinants

American Journal of Obstetrics & Gynecology MFM(2023)10.1016/j.ajogmf.2023.101173

N/A

0DataRank · unranked

4 citations

Erin Britton, Hannah Shadowen, Jasmine Johnson, Roy Sabo, Peter Cunningham +1 more

Rapid induction onto extended-release injectable buprenorphine following opioid overdose: A case series

Drug and Alcohol Dependence Reports(2023)10.1016/j.dadr.2023.100144

N/A

0DataRank · unranked

7 citations

Katy J. Ringwood, Theresa T. Davis, Tamas S. Gal, Brandon K. Wills, Roy Sabo +6 more

Development and clinical feasibility study of a brief version of an addiction‐focused phenotyping battery in females receiving buprenorphine for opioid use disorder

Brain and Behavior(2023)10.1002/brb3.3128

N/A

0DataRank · unranked

5 citations

Michelle Eglovitch, Catherine Legge, Lori Keyser‐Marcus, James M. Bjork, Amanda Adams +4 more

Commentary on Nowakowski et al.: Bringing the participants’ own words into addictions research—a win–win for patients and investigators

Addiction(2023)10.1111/add.16190

N/A

0DataRank · unranked

3 citations

Caitlin E. Martin

0676 Sleep medication prescribing among patients receiving opioid use disorder treatment with comorbid insomnia

SLEEP(2023)10.1093/sleep/zsad077.0676

N/A

0DataRank · unranked

0 citations

Hetal Patel, Joseph M. Dzierzewski, F. Gerard Moeller, Laura J. Bierut, Richard A. Grucza +2 more

Insomnia symptoms and neurofunctional correlates among adults receiving buprenorphine for opioid use disorder

PLoS ONE(2024)10.1371/journal.pone.0304461

N/A

0DataRank · unranked

10 citations

Michelle Eglovitch, Anna Beth Parlier‐Ahmad, Joseph M. Dzierzewski, Morgan H. James, James M. Bjork +3 more

Prescription psychostimulant use, admissions and treatment initiation and retention in pregnant people with opioid use disorder

Nature Mental Health(2024)10.1038/s44220-024-00270-w

N/A

0DataRank · unranked

4 citations

Tiffani D.M. Berkel, Caitlin E. Martin, Hendrée E. Jones, Ebony B. Carter, Jeannie C. Kelly +4 more

Profiling the sleep architecture of ageing adults using a seven‐state continuous‐time Markov model

Journal of Sleep Research(2024)10.1111/jsr.14331

N/A

0DataRank · unranked

4 citations

Caitlin E. Martin, Bernard F. Fuemmeler, S. Chen, Jonathon Jacobs

Post-traumatic stress disorder symptomatology is associated with insomnia among women engaged in opioid use disorder treatment with buprenorphine

Archives of Women s Mental Health(2024)10.1007/s00737-024-01487-5

N/A

0DataRank · unranked

2 citations

Susie Turkson, Michelle Eglovitch, Dace S. Svikis, Gretchen N. Neigh, Caitlin E. Martin +1 more

Sex and Gender Differences in Weight-Related Biopsychosocial Factors Among Adults Receiving Buprenorphine for Opioid Use Disorder

Substance Use &amp Addiction Journal(2024)10.1177/29767342241303220

N/A

0DataRank · unranked

1 citations

Taylor A. Ochalek, Melanie K. Bean, Susan Wolver, Salvatore Carbone, Leila Z. Islam +3 more

Commentary on Cochran et al.: Meeting people where they are in addictions research

Addiction(2024)10.1111/add.16418

N/A

0DataRank · unranked

1 citations

Caitlin E. Martin

Neurofunction and Insomnia Symptoms Among Women in Treatment for Opioid Use Disorder

Drug and Alcohol Dependence(2024)10.1016/j.drugalcdep.2023.110678

N/A

0DataRank · unranked

0 citations

Michelle Eglovitch, Anna Beth Parlier‐Ahmad, Jospeh Dzierewski, F. Gerard Moeller, Caitlin E. Martin +1 more

Discontinuation of treatment for alcohol use disorder during pregnancy and postpartum in the United States

Alcohol Clinical and Experimental Research(2025)10.1111/acer.70117

N/A

0DataRank · unranked

2 citations

Jennifer K. Bello, Bridget M. Galati, Joanna L. Buss, Mishka Terplan, Hendrée E. Jones +6 more

Neurofunctional phenotyping to investigate the role of the orexin system at the intersection of opioid use disorder and insomnia: a protocol for a randomised, placebo-controlled clinical trial of lemborexant in patients with insomnia receiving buprenorphine

BMJ Open(2025)10.1136/bmjopen-2025-108613

N/A

0DataRank · unranked

0 citations

Maha Alattar, Shanshan Chen, Roy Sabo, Tiffany Pignatello, Joyce Ruddley +6 more

Postpartum buprenorphine continuation by initiation setting

American Journal of Obstetrics & Gynecology MFM(2025)10.1016/j.ajogmf.2025.101783

N/A

0DataRank · unranked

0 citations

Madison M. Marcus, Hannah Shadowen, Nicole Boss, Amy L. Salisbury, Alison N. Goulding +2 more